| Limited Competition—A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)- RFA-CA-22-026 |
U24
|
June 14, 2022 |
September 16, 2022 |
| Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)- RFA-ES-22-003 |
U24
|
June 06, 2022 |
August 26, 2022 |
| Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed) - RFA-NS-22-051 |
U2C
|
June 06, 2022 |
August 11, 2022 |
| A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed)- RFA-AI-22-038 |
P01
|
May 27, 2022 |
October 14, 2022 |
| Understanding the Clinical History of Bacterial Sexually Transmitted Infections (STI) to Accelerate Diagnostic and Vaccine Development (R01 Clinical Trial Not Allowed)- RFA-AI-22-034 |
R01
|
May 12, 2022 |
September 13, 2022 |
| Partnerships for Development of Vaccines Against Select Enteric Pathogens (R01 Clinical Trial Not Allowed)- RFA-AI-22-037 |
R01
|
May 10, 2022 |
September 15, 2022 |
| Limited Interaction Targeted Epidemiology—Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)- RFA-AI-22-024 |
UG3/UH3
|
April 13, 2022 |
August 04, 2022 |
| Small Research Grants for Analysis, Curation, and/or Sharing of Down syndrome-related Research Data for the INCLUDE Project (R03 Clinical Trial Not Allowed)- RFA-OD-22-008 |
R03
|
April 08, 2022 |
July 02, 2024 |
| Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 |
UH2/UH3
|
April 05, 2022 |
July 02, 2022 |
| Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 |
R01
|
April 05, 2022 |
July 30, 2022 |
| Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)- RFA-OD-22-009 |
R01
|
April 05, 2022 |
July 02, 2024 |
| Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 |
R01
|
March 29, 2022 |
August 04, 2022 |
| Limited Competition—Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38 Clinical Trial Not Allowed)- RFA-HL-23-007 |
K38
|
March 14, 2022 |
January 11, 2025 |
| Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 |
R61/R33
|
March 10, 2022 |
August 04, 2022 |
| Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 |
R01
|
March 02, 2022 |
July 09, 2022 |
| Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)- RFA-AI-22-012 |
U01
|
February 24, 2022 |
July 02, 2022 |
| Stimulating Access to Research in Residency (StARR) (R38)- RFA-HL-23-006 |
R38
|
January 19, 2022 |
May 17, 2024 |
| INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)- RFA-OD-21-007 |
R21
|
September 24, 2021 |
July 02, 2024 |
| Support for Small Business Innovation Research (SBIR) to Develop New Methods and Technologies for Assessment of Risk and for Early Diagnosis and Prognosis of Type 1 Diabetes (R43/R44 Clinical Trial Not Allowed)- RFA-DK-21-021 |
R43/R44
|
June 25, 2021 |
October 08, 2022 |
| CCRP Initiative—Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)- RFA-ES-21-006 |
R01
|
June 25, 2021 |
September 21, 2023 |
| Exploratory Data Science Methods and Algorithm Development in Infectious and Immune-mediated Diseases (R21 Clinical Trial Not Allowed)- RFA-AI-21-035 |
R21
|
March 17, 2021 |
July 07, 2023 |
| Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)- RFA-AI-21-020 |
U01
|
March 17, 2021 |
July 07, 2023 |
| New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)- RFA-AI-20-076 |
R01
|
October 20, 2020 |
March 18, 2023 |
